• Lakshmi Pradeepthi Pemmaraju
• Alavala Matta Reddy
• P.Vijaya Nirmala
• Abhinash Marukurti
• Buddha Sai Keeerthana

Discovering new targets for drug development is a crucial phase in drug identification. Drug discovery is a time-consuming and expensive endeavor, especially when addressing complex conditions such as Parkinson's disease. Mutations in the SNCA gene are responsible for Parkinson's disease. The SNCA gene is part of the PARK gene family associated with Parkinson's disease. The paper's primary focus centers around the discussion of virtual screening and docking methods and software tools utilized for molecular docking in the context of Parkinson's disease.

Virtual Screening, In-silico design, Docking, Computer-aided drug design, and Drug discovery.

"MOLECULAR DOCKING AND VIRTUAL SCREENING IN DRUG DESIGN FOR PARKINSON'S DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 12, page no.1-5, December-2023, Available :http://www.jetir.org/papers/JETIRGA06001.pdf

"MOLECULAR DOCKING AND VIRTUAL SCREENING IN DRUG DESIGN FOR PARKINSON'S DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 12, page no. pp1-5, December-2023, Available at : http://www.jetir.org/papers/JETIRGA06001.pdf